Trial intelligence / Profile preview

PK of NES/EE CVR with Miconazole Nitrate

NCT02215395Phase 1Completed

Sponsor
Population Council
Start
Mar 2014
Primary completion
Apr 2015
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 1, randomised, open-label trial of segesterone and ethinyl estradiol, sponsored by Population Council. Primary endpoint: Drug Drug Interaction of NES/EE CVR and topical anti-fungal medication at Week 12. Started Mar 2014; status: completed.

02

Drugs

segesteroneethinyl estradiol

Beyond the preview

Go deeper on NCT02215395.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02215395.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call